Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2484 studies found for:    "Anticoagulants"
Show Display Options
Rank Status Study
1 Active, not recruiting Intracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic Resonance
Condition: Ischemic Stroke
Intervention: Drug: oral anticoagulants
2 Active, not recruiting D-dimer to Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months
Conditions: Deep Vein Thrombosis;   Pulmonary Embolism
Interventions: Other: Discontinue anticoagulant therapy (Negative d-dimer);   Other: Continue on anticoagulant therapy (positive d-dimer)
3 Not yet recruiting Bleeding Frequency Under Anticoagulant Treatment in Pulmonary Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Oral anticoagulant treatment
4 Completed Anticoagulant Clinics and Vitamin K Antagonists
Condition: Blood Coagulation Disorders
Intervention: Drug: Anticoagulant (warfarin, acenocoumarol, fluindione)
5 Not yet recruiting Safety of Oral Anticoagulants Registry
Condition: Blood Coagulation
Intervention: Other: mgt of bleeding concerns/complications of oral anticoagulants
6 Recruiting Direct Oral Anticoagulants Pharmacodynamics in Octogenarian Patients With Atrial Fibrillation
Condition: Atrial Fibrillation and Flutter
Intervention: Other: New oral anticoagulant pharmacodynamic analysis (blood level assesment)
7 Not yet recruiting SILENT - Subclinical AtrIal FibrilLation and StrokE PreveNtion Trial
Condition: Atrial Fibrillation
Intervention: Drug: anticoagulant by physician criteria
8 Completed Stroke Prophylaxis of AF-patients: Real-life Effectiveness and Safety of Novel Anticoagulants Compared to VKA
Conditions: Atrial Fibrillation;   Stroke Prophylaxis
Interventions: Drug: vitamin-k-antagonists;   Drug: Novel oral anticoagulants
9 Active, not recruiting START-Register: Survey on Anticoagulated Patients Register
Conditions: Atrial Fibrillation;   Venous Thromboembolism;   Heart Valve Diseases or Prosthesis
Intervention: Drug: Anticoagulants
10 Recruiting Clinical Trial for Optimal Novel Oral Anticoagulant (NOAC) Schedule Immediate Before Catheter Ablation for Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: novel oral anticoagulant for 30 days;   Drug: novel oral anticoagulant for 24 hour
11 Completed
Has Results
Rhythm Evaluation for AntiCoagulaTion With COntinuous Monitoring
Condition: Atrial Fibrillation
Intervention: Drug: Non-coumadin Oral Anticoagulant
12 Completed Prospective Evaluation of Bleeding Risk of Anticoagulant and Anti-platelet Therapy
Condition: Bleeding
Intervention: Drug: Antithrombotics
13 Suspended Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer
Condition: Colon Cancer
Intervention: Drug: recombinant nematode anticoagulant protein c2 (rNAPc2)
14 Completed An Observational Cross-sectional Study Evaluating the Use of Re-sources and the Sociodemographic and Clinical Characteristics of Patients Diagnosed With Non-valvular Atrial Fibrillation With a Risk of Stroke or Systemic Embolism on Anticoagulant Therapy and Treated in Primary Care Centers
Conditions: Stroke;   Prevention and Control;   Atrial Fibrillation
Intervention: Drug: Xarelto, Pradaxa and Eliquis
15 Recruiting Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime
Conditions: Ischemic Stroke;   Intracerebral Hemorrhage;   Oral Anticoagulation;   Cardiovascular Diseases;   Vascular Diseases
Intervention: Other: not applicable (observational study)
16 Completed Assays for and Reversal of New Anticoagulants
Conditions: Atrial Fibrillation;   Osteoarthritis of the Knee;   Osteoarthritis of the Hip
Intervention:
17 Recruiting A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With PEG L-Asparaginase
Conditions: Lymphoma;   Acute Lymphoblastic Leukemia
Interventions: Drug: Apixaban;   Other: No systemic anticoagulant prophylaxis
18 Enrolling by invitation Addressing Real-world Anticoagulant Management Issues in Stroke
Conditions: Stroke;   Cerebrovascular Stroke;   Intracerebral Hemorrhage
Intervention:
19 Unknown  Benefits of a Comprehensive Patient Education on Oral Anticoagulant Compared to Conventional Hospital Education
Condition: Cardiac Surgery
Interventions: Behavioral: VKA (antivitamin K) education;   Behavioral: conventional hospital education
20 Recruiting Exposure of Salvaged Blood to Inflammation and Oxidative Stress: the Effect of Different Anticoagulant Regimes (HECICS)
Condition: Intra Operative Bleeding, Blood Salvage
Interventions: Drug: ACD-A;   Drug: Heparin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.